Soligenix Inc (SNGX)
0.427
+0.04
(+11.49%)
USD |
NASDAQ |
Apr 25, 16:00
0.429
0.00 (0.00%)
After-Hours: 06:09
Soligenix Cash from Financing (TTM): 3.664M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 3.664M |
September 30, 2023 | 3.786M |
June 30, 2023 | 3.962M |
March 31, 2023 | -0.8547M |
December 31, 2022 | 0.0768M |
September 30, 2022 | 0.2508M |
June 30, 2022 | 3.114M |
March 31, 2022 | 3.202M |
December 31, 2021 | 19.06M |
September 30, 2021 | 30.24M |
June 30, 2021 | 30.49M |
March 31, 2021 | 36.02M |
December 31, 2020 | 24.68M |
September 30, 2020 | 14.80M |
June 30, 2020 | 13.33M |
March 31, 2020 | 8.016M |
December 31, 2019 | 4.006M |
September 30, 2019 | 2.387M |
June 30, 2019 | 9.195M |
March 31, 2019 | 8.909M |
December 31, 2018 | 8.424M |
September 30, 2018 | 13.64M |
June 30, 2018 | 5.589M |
March 31, 2018 | 5.594M |
December 31, 2017 | 5.574M |
Date | Value |
---|---|
September 30, 2017 | 4.964M |
June 30, 2017 | 8.242M |
March 31, 2017 | 8.860M |
December 31, 2016 | 8.841M |
September 30, 2016 | 6.522M |
June 30, 2016 | 3.186M |
March 31, 2016 | 3.781M |
December 31, 2015 | 4.805M |
September 30, 2015 | 4.519M |
June 30, 2015 | 4.349M |
March 31, 2015 | 3.283M |
December 31, 2014 | 2.436M |
September 30, 2014 | 1.072M |
June 30, 2014 | 1.078M |
March 31, 2014 | 7.133M |
December 31, 2013 | 6.975M |
September 30, 2013 | 6.401M |
June 30, 2013 | 6.224M |
March 31, 2013 | 0.00 |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 0.6494M |
September 30, 2011 | 0.6674M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.8547M
Minimum
Mar 2023
36.02M
Maximum
Mar 2021
11.02M
Average
4.006M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Eagle Pharmaceuticals Inc | 11.92M |
Marinus Pharmaceuticals Inc | 26.63M |
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |